Effects of Omega-3 Fatty Acid Supplementation on Vascular Access Thrombosis in Polytetrafluorethylene Grafts

Journal of Renal Nutrition

Volumn 17, Issue 2, 2007, Pages 126-131

  Bowden, Rodney G ^a   Wilson, Ronald L ^b   Gentile, Mindy ^c   Ounpraseuth, Songthip ^a   Moore, Page ^a   Leutholtz, Brian C ^a  

^a BAYLOR UNIVERSITY   (United States)

^b Nephrology Associates   (United States)

^c Brazos Kidney Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; OMEGA 3 FATTY ACID; POLITEF;

ARTERIOVENOUS SHUNT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; VASCULAR PATENCY;

ARTERIOVENOUS SHUNT, SURGICAL; BIOCOMPATIBLE MATERIALS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; HUMANS; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; THROMBOSIS; VASCULAR PATENCY;

FISTULA;

EID: 33847198682     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.07.009     Document Type: Article

References (23)

1. Joseph S., and Adler S. Vascular access problems in dialysis patients. Heart Dis 3 (2001) 242-247
2. Shemin D., Lapane K.L., Bausserman L., et al. Plasma total homocysteine and hemodialysis access thrombosis: A prospective study. J Am Soc Nephrol 10 (1999) 1095-1099
3. Rodriquez J.A., Armadans L., Ferrer E., et al. The function of permanent vascular access. Nephrol Dial Trans 15 (2000) 402-408
4. Feldman H.I., and Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 7 (1996) 523-535
5. Hojs R., Gorenjak M., Ekart R., et al. Homocysteine and vascular access thrombosis in hemodialysis patients. Renal Failure 24 (2002) 215-222
6. Roy-Chaudhury P., Kelley B.S., Narayana A., et al. Hemodialysis vascular access thrombosis dysfunction from basic biology to clinical intervention. Adv Ren Replace Ther 9 (2002) 74-78
7. Feldman H.I., Held P.J., Hutchinson J.T., et al. Hemodialysis vascular access morbidity in the United States. Kidney Int 43 (1993) 1091-1096
8. Donadio J.V. n-3 fatty acids and their role in nephrologic practice. Curr Opin Nephrol Hypertens 10 (2001) 639-642
9. Bowden R.G., Wyatt F.B., Wilson R.L., et al. Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients. Ren Fail 26 (2004) 709-714
10. Schmitz P.G., McCloud L.K., Reikes S.T., et al. Prophylaxis of hemodialysis graft thrombosis with fish oil: Double-blind, randomized, prospective trial. J Am Soc Nephrol 13 (2002) 184-190
11. Moist L.M., Churchill D.N., House A.A., et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 14 (2003) 2645-2653
12. Saran R., Dykstra D.M., Wolfe R.A., et al. Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 40 (2002) 1255-1263
13. Sreedhara R., Himmelfarb J., Lazarus J.M., et al. Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized double-blind study. Kidney Int 45 (1994) 1477-1483
14. Kaufman J.S., O'Conner T.Z., Zhang J.H., et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14 (2003) 2313-2321
15. Sullivan K.L., and Besarab A. Hemodynamic screening and early percutaneous intervention reduce hemodialysis access thrombosis and increase graft longevity. J Vasc Interv Radiol 8 (1997) 163-170
16. Schmitz P.G., and Antony K.A. Omega-3 fatty acids in ESRD: Should patients with ESRD eat more fish?. Nephrol Dial Transplant 17 (2002) 11-14
17. Tatsioni A., Chung M., Sun Y., et al. Effects of fish oil supplementation on kidney transplantation: A systematic review and meta-analysis of randomized, controlled trials. J Am Soc Nephrol 16 (2005) 2462-2470
18. Vergili-Nelsen J.M. Benefits of fish oil supplementation for hemodialysis patients. J Am Diet Assoc 103 (2003) 1174-1177
19. Bowden R.G., Wyatt F., and Wilson R. Homocysteine and vascular access thrombosis in end-stage renal disease patients: A retrospective study. J Nephrol 15 (2002) 666-670
20. Diskin C.J., Thomas C.E., Zellner C.P., et al. Fish oil to prevent intimal hyperplasia and access thrombosis. Nephron 55 (1990) 445-447
21. Freedman L.S. Tables of the numbers of patients required in clinical trials using the log-rank test. Stat Med 1 (1982) 121-129
22. Rodriquez J.A., Armadans L., Ferrer E., et al. The function of permanent vascular access. Nephrol Dial Trans 15 (2000) 402-408
23. Silver R.C., and Cain J.A. Managing the lifeline: Preemptive access management for better outcomes for hemodialysis patients and programs. Adv Ren Rep Ther 7 suppl 1 (2000) S45-S55